Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lambros Vamvakas
Capecitabine in Combination With Oxaliplatin and Bevacizumab (AXELOX) as 1st Line Treatment for Fit and Vulnerable Elderly Patients (Aged >70 Years) With Metastatic Colorectal Cancer (mCRC): A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG)
BMC Cancer
Cancer Research
Oncology
Genetics
Central Nervous System Relapse in Patients With Breast Cancer Is Associated With Advanced Stages, With the Presence of Circulating Occult Tumor Cells and With the HER2/neu Status
Breast Cancer Research
Cancer Research
Oncology
Related publications
Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Nab-Paclitaxel as Second-Line Treatment in Advanced Gastric Cancer: A Multicenter Phase II Study of the Hellenic Oncology Research Group
Annals of Gastroenterology
A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-Line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
Multicenter Phase II Study of Docetaxel Plus Oxaliplatin Combination Chemotherapy in Patients With Advanced Gastric Cancer: Daegu Gyeongbuk Oncology Group
British Journal of Cancer
Cancer Research
Oncology
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients With Recurrent or Metastatic Biliary Tract Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Second-Line Pazopanib in Patients With Relapsed and Refractory Small-Cell Lung Cancer: A Multicentre Phase II Study of the Hellenic Oncology Research Group
British Journal of Cancer
Cancer Research
Oncology
Capecitabine and Oxaliplatin in Combination as First- Or Second-Line Therapy for Metastatic Breast Cancer: A Wisconsin Oncology Network Trial
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
